Are you Dr. Chan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 83 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 Tvc
Nashville, TN 37232Phone+1 615-322-3000- Is this information wrong?
Summary
- Dr. Emily Chan, MD is an oncologist in Nashville, Tennessee. She is currently licensed to practice medicine in Tennessee. She is affiliated with Tennessee Valley HCS - Nashville and Murfreesboro and is an Assistant Professor at Vanderbilt University School of Medicine.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2005
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
Weill Cornell MedicineClass of 1998
Certifications & Licensure
TN State Medical License 2005 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Vitamin D in Untreated Metastatic Colorectal Cancer Start of enrollment: 2012 Apr 13
- Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting Start of enrollment: 2014 Feb 05
- A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab Start of enrollment: 2014 May 05
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsDifferential Immunohistochemical and Molecular Profiling of Conventional and Aggressive Components of Chromophobe Renal Cell Carcinoma: Pitfalls for Diagnosis.Constance V. Chen, Nicole A. Croom, Jeffry P. Simko, Bradley A. Stohr, Emily Chan> ;Human Pathology. 2021 Nov 17
- 7 citationsPapillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic DiseaseEmily Chan, Bradley A. Stohr, Robert S. Butler, Roni M. Cox, Jonathan Myles, Jane K. Nguyen, Christopher G. Przybycin, Jordan P. Reynolds, Sean R. Williamson, Jesse K....> ;The American Journal of Surgical Pathology. 2021 Sep 9
- 19 citationsTERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor.Ivan de Kouchkovsky, Li Zhang, Errol J. Philip, Francis Wright, Daniel M Kim, Divya Natesan, Daniel Kwon, Hansen Ho, Son Ho, Emily Chan, Sima P. Porten, Anthony C. Won...> ;Journal for Immunotherapy of Cancer. 2021 May 1
- Join now to see all
Press Mentions
Completion of Adjuvant Chemotherapy After Pancreatic Resection Linked with Improved SurvivalJanuary 18th, 2014
Professional Memberships
- Member
Hospital Affiliations
Tennessee Valley HCS - Nashville and MurfreesboroNashville, Tennessee
